Jiangxi Fushine Pharmaceutical Co Ltd (300497) - Cash Flow Conversion Efficiency

Latest as of September 2025: 0.008x

Based on the latest financial reports, Jiangxi Fushine Pharmaceutical Co Ltd (300497) has a cash flow conversion efficiency ratio of 0.008x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥18.31 Million ≈ $2.68 Million USD) by net assets (CN¥2.17 Billion ≈ $317.24 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See operational self-sufficiency of Jiangxi Fushine Pharmaceutical Co Ltd to measure how many days the company can operate on defensive assets alone.

Jiangxi Fushine Pharmaceutical Co Ltd - Cash Flow Conversion Efficiency Trend (2011–2025)

This chart illustrates how Jiangxi Fushine Pharmaceutical Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data.

Jiangxi Fushine Pharmaceutical Co Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Jiangxi Fushine Pharmaceutical Co Ltd ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
Qisda Corp TW:2352	-0.072x
Devyani International Limited NSE:DEVYANI	0.095x
Minera Valparaiso S.A. SN:MINERA	0.026x
Chengzhi Shareholding Co Ltd SHE:000990	0.016x
Yantai Dongcheng Pharmaceutical Co Ltd SHE:002675	0.044x
Beijing Lier High Temperature Materials Co Ltd SHE:002392	0.010x
Healthcare Services Group Inc NASDAQ:HCSG	0.085x
DOMS Industries Limited NSE:DOMS	0.046x

Annual Cash Flow Conversion Efficiency for Jiangxi Fushine Pharmaceutical Co Ltd (2011–2025)

The table below shows the annual cash flow conversion efficiency of Jiangxi Fushine Pharmaceutical Co Ltd from 2011 to 2025. For the full company profile with market capitalisation and key ratios, see 300497 company net worth.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-12-31	CN¥2.20 Billion ≈ $321.96 Million	CN¥62.67 Million ≈ $9.17 Million	0.028x	-66.95%
2024-12-31	CN¥2.18 Billion ≈ $318.55 Million	CN¥187.64 Million ≈ $27.46 Million	0.086x	+428.84%
2023-12-31	CN¥2.47 Billion ≈ $361.55 Million	CN¥-64.76 Million ≈ $-9.48 Million	-0.026x	+41.66%
2022-12-31	CN¥2.69 Billion ≈ $393.58 Million	CN¥-120.85 Million ≈ $-17.68 Million	-0.045x	-280.87%
2021-12-31	CN¥2.91 Billion ≈ $426.02 Million	CN¥72.32 Million ≈ $10.58 Million	0.025x	-80.20%
2020-12-31	CN¥3.05 Billion ≈ $445.98 Million	CN¥382.35 Million ≈ $55.95 Million	0.125x	-43.29%
2019-12-31	CN¥1.53 Billion ≈ $223.52 Million	CN¥337.91 Million ≈ $49.45 Million	0.221x	+44.20%
2018-12-31	CN¥1.15 Billion ≈ $167.80 Million	CN¥175.91 Million ≈ $25.74 Million	0.153x	-29.62%
2017-12-31	CN¥966.71 Million ≈ $141.46 Million	CN¥210.72 Million ≈ $30.84 Million	0.218x	-9.34%
2016-12-31	CN¥784.17 Million ≈ $114.75 Million	CN¥188.53 Million ≈ $27.59 Million	0.240x	+93.69%
2015-12-31	CN¥596.21 Million ≈ $87.24 Million	CN¥74.01 Million ≈ $10.83 Million	0.124x	+12.02%
2014-12-31	CN¥283.26 Million ≈ $41.45 Million	CN¥31.39 Million ≈ $4.59 Million	0.111x	-55.50%
2013-12-31	CN¥229.76 Million ≈ $33.62 Million	CN¥57.22 Million ≈ $8.37 Million	0.249x	-27.25%
2012-12-31	CN¥184.60 Million ≈ $27.01 Million	CN¥63.20 Million ≈ $9.25 Million	0.342x	+22.08%
2011-12-31	CN¥120.52 Million ≈ $17.64 Million	CN¥33.80 Million ≈ $4.95 Million	0.280x	--

About Jiangxi Fushine Pharmaceutical Co Ltd

SHE:300497 China Biotechnology

Market Cap

$1.54 Billion

CN¥10.49 Billion CNY

Market Cap Rank

#7280 Global

#1670 in China

Share Price

CN¥19.48

Change (1 day)

+6.92%

52-Week Range

CN¥8.69 - CN¥21.15

All Time High

CN¥24.76